Spatheliachromen mitigates methylglyoxal-induced myotube atrophy by activating Nrf2, inhibiting ubiquitin-mediated protein degradation, and restoring mitochondrial function

Chuang Y.-F. and Cheng L. and Chang W.-H. and Yu Szu-Yin and Hsu H.-T. and An L.-M. and Yen C.-H. and Chang F.-R. and Lo Y.-C.: Spatheliachromen mitigates methylglyoxal-induced myotube atrophy by activating Nrf2, inhibiting ubiquitin-mediated protein degradation, and restoring mitochondrial function.
EUROPEAN JOURNAL OF PHARMACOLOGY, 984. ISSN 0014-2999 (2024)

[thumbnail of 1-s2.0-S001429992400760X-main.pdf] Text
1-s2.0-S001429992400760X-main.pdf - Published Version
Closed access: Repository staff only

Download (11MB) | Request a copy
Creators:
Chuang Y.-F.
Cheng L.
Chang W.-H.
Yu Szu-Yin MTMT
Hsu H.-T.
An L.-M.
Yen C.-H.
Chang F.-R.
Lo Y.-C.
Item Type: Journal Article
Journal or Publication Title: EUROPEAN JOURNAL OF PHARMACOLOGY
Date: 2024
Volume: 984
Number of Pages: 15
Publication identifier: 177070
ISSN: 0014-2999
Faculty/Unit: Faculty of Pharmacy
Institution: University of Szeged (2000-)
Language: English
MTMT rekordazonosító: 35590836
DOI azonosító: https://doi.org/10.1016/j.ejphar.2024.177070
Date Deposited: 2025. Jun. 20. 10:05
Last Modified: 2025. Jun. 20. 10:05
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/37029

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year